Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Liver and Bile

    Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis

    J Hepatol. 2023;78(3):604–13

    Villard C, Friis-Liby I, Rorsman F, Said K, Warnqvist A, Cornillet M, Kechagias S, Nyhlin N, Werner M, Janczewska I, Hagström T, Nilsson E, Bergquist A

    Go to article

    Liver and Bile

    Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis

    J Hepatol. 2023;78(1):114–22

    Baiges A, Procopet B, Silva-Junior G, Llop E, Tellez L, Darnell A, Garcia-Criado Á, Turon F, Nicoara-Farcau O, González-Alayón C, Larrue H, Magaz M, Olivas P, Perez-Campuzano V, Calleja JL, Albillos A, Reverter JC, Bureau C, Bosch J, Hernández-Gea V, Garcia-Pagán JC; Registro Español de Enfermedades Hepáticas Vasculares (REHEVASC) consortium, Vascular Liver Diseases Interest Group (VALDIG), EASL consortium

    Go to article

    Liver and Bile

    Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl

    J Gastroenterol Hepatol. 2023;38(2):219–24

    Mohr I, Bourhis H, Woimant F, Obadia MA, Morgil M, Morvan E, Merle U, Denk G, Poujois A, Weiss KH

    Go to article

    Liver and Bile

    Treatment of refractory hepatic encephalopathy induced by spontaneous portosystemic shunt: Selective splenic vein embolization versus shunt embolization

    Dig Liver Dis. 2023;55(3):381–6

    Zhang L, Wei B, Wang Z, Tong H, Wu H

    Go to article

    Liver and Bile

    Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation

    Hepatology. 2023;77(2):430–42

    Demory A, Péron JM, Calderaro J, Selves J, Mokrane FZ, Amaddeo G, Paradis V, Ziol M, Sutter O, Blaise L, Ganne-Carrié N, Vilgrain V, Cauchy F, Zucman-Rossi J, Ronot M, Nault JC

    Go to article

    Liver and Bile

    Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: The ITA.LI.CA database

    Gut. 2023;72(1):141–52

    Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group

    Go to article

    Liver and Bile

    Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma

    N Engl J Med. 2023;388(3):228–39

    Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators

    Go to article

    Liver and Bile

    Risk factors for HCC in contemporary cohorts of patients with cirrhosis

    Hepatology. 2023;77(3):997–1005

    Kanwal F, Khaderi S, Singal AG, Marrero JA, Loo N, Asrani SK, Amos CI, Thrift AP, Gu X, Luster M, Al-Sarraj A, Ning J, El-Serag HB

    Go to article

    Liver and Bile

    Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

    Gastroenterology. 2023;164(1):72–88.e18

    Haber PK, Castet F, Torres-Martin M, Andreu-Oller C, Puigvehí M, Miho M, Radu P, Dufour JF, Verslype C, Zimpel C, Marquardt JU, Galle PR, Vogel A, Bathon M, Meyer T, Labgaa I, Digklia A, Roberts LR, Mohamed Ali MA, Mínguez B, Citterio D, Mazzaferro V, Finkelmeier F, Trojan J, Özdirik B, Müller T, Schmelzle M, Bejjani A, Sung MW, Schwartz ME, Finn RS, Thung S, Villanueva A, Sia D, Llovet JM

    Go to article